Six weeks open-label oral ketamine for patients with treatment-resistant depression, post-traumatic stress disorder, or obsessive-compulsive disorder
为期六周的开放标签口服氯胺酮治疗难治性抑郁症、创伤后应激障碍或强迫症患者
期刊:Journal of Psychopharmacology
影响因子:5.5
doi:10.1177/02698811251344710
Beaglehole, Ben; Glue, Paul; Neehoff, Shona; Shadli, Shabah; McNaughton, Neil; Kimber, Bridget; Muirhead, Chrissie; de Bie, Aroha; Day-Brown, Rachel; Hughes-Medlicott, Natalie J